FDA Corrects Notice on TYZEKA Patent Extension Review Period

Summary

The US Food and Drug Administration (FDA) is correcting a notice that incorrectly stated the regulatory review period for TYZEKA, a patent extension, published in the Federal Register on May 15, 2008.